DK107787A - Fremgangsmaade og praeparat til behandling af cancer og ikke-maligne tumorer - Google Patents

Fremgangsmaade og praeparat til behandling af cancer og ikke-maligne tumorer

Info

Publication number
DK107787A
DK107787A DK107787A DK107787A DK107787A DK 107787 A DK107787 A DK 107787A DK 107787 A DK107787 A DK 107787A DK 107787 A DK107787 A DK 107787A DK 107787 A DK107787 A DK 107787A
Authority
DK
Denmark
Prior art keywords
cancer
treatment
tumors
compositions
temporary
Prior art date
Application number
DK107787A
Other languages
Danish (da)
English (en)
Other versions
DK107787D0 (da
Inventor
Gary R Landucci
Toni N Mariani
Original Assignee
Univ Minnesota
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Minnesota filed Critical Univ Minnesota
Publication of DK107787A publication Critical patent/DK107787A/da
Publication of DK107787D0 publication Critical patent/DK107787D0/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/44—Antibodies bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the cancer treated
    • A61K2239/48—Blood cells, e.g. leukemia or lymphoma
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/24—Interferons [IFN]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
DK107787A 1985-06-28 1987-03-02 Fremgangsmaade og praeparat til behandling af cancer og ikke-maligne tumorer DK107787D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75009185A 1985-06-28 1985-06-28
PCT/US1986/001348 WO1987000054A1 (en) 1985-06-28 1986-06-26 Process and composition for treatment of cancer and non-malignant tumors

Publications (2)

Publication Number Publication Date
DK107787A true DK107787A (da) 1987-03-02
DK107787D0 DK107787D0 (da) 1987-03-02

Family

ID=25016458

Family Applications (1)

Application Number Title Priority Date Filing Date
DK107787A DK107787D0 (da) 1985-06-28 1987-03-02 Fremgangsmaade og praeparat til behandling af cancer og ikke-maligne tumorer

Country Status (13)

Country Link
EP (1) EP0227809B1 (de)
JP (1) JPS62503144A (de)
CN (1) CN86104913A (de)
AT (1) ATE80802T1 (de)
AU (1) AU597265B2 (de)
CA (1) CA1341303C (de)
DE (1) DE3686811D1 (de)
DK (1) DK107787D0 (de)
ES (1) ES8800981A1 (de)
HU (1) HUT43495A (de)
IL (1) IL79260A (de)
WO (1) WO1987000054A1 (de)
ZA (1) ZA864769B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192537A (en) * 1984-03-30 1993-03-09 Cellcor Inc. Method of treating renal cell carcinoma using activated mononuclear cells, renal tumor antigen and cimetidine
US4894227A (en) * 1986-08-01 1990-01-16 Cetus Corporation Composition of immunotoxins with interleukin-2
US4863726A (en) * 1987-05-29 1989-09-05 Cetus Corporation Combination therapy using immunotoxins with interleukin-2
AU2925789A (en) * 1987-12-17 1989-07-19 Browning's Clinical Pathology Services Limited Lymphokine activation of cells for adoptive immunotherapy, e.g. of hiv infection
US5834441A (en) * 1993-09-13 1998-11-10 Rhone-Poulenc Rorer Pharmaceuticals Inc. Adeno-associated viral (AAV) liposomes and methods related thereto
US6652850B1 (en) 1993-09-13 2003-11-25 Aventis Pharmaceuticals Inc. Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity
US20020168347A1 (en) * 1998-04-09 2002-11-14 Jacques Bartholeyns Use of monocytes derived cells, antigens and antibodies for optimal induction of immunotherapeutic efficiency
AU3601299A (en) * 1998-04-09 1999-11-01 I.D.M. Immuno-Designed Molecules Use of monocytes derived cells and antibodies in a synergic way for optimal induction of immunotherapeutic efficiency
US6868665B2 (en) 2001-12-21 2005-03-22 General Electric Company Methods and apparatus for operating gas turbine engines
US7200538B2 (en) 2003-01-15 2007-04-03 General Electric Company Methods and apparatus for modeling gas turbine engines

Also Published As

Publication number Publication date
ZA864769B (en) 1987-02-25
IL79260A0 (en) 1986-09-30
EP0227809B1 (de) 1992-09-23
CN86104913A (zh) 1987-05-27
ATE80802T1 (de) 1992-10-15
HUT43495A (en) 1987-11-30
IL79260A (en) 1990-11-29
ES8800981A1 (es) 1987-12-01
AU597265B2 (en) 1990-05-31
JPS62503144A (ja) 1987-12-17
DK107787D0 (da) 1987-03-02
EP0227809A4 (de) 1987-10-19
CA1341303C (en) 2001-10-09
DE3686811D1 (de) 1992-10-29
AU6125486A (en) 1987-01-30
ES556684A0 (es) 1987-12-01
EP0227809A1 (de) 1987-07-08
WO1987000054A1 (en) 1987-01-15

Similar Documents

Publication Publication Date Title
ES8103976A1 (es) Un metodo de producir proteinas de interferon humano de for-ma le
UA29494C2 (uk) Гуманізовані антитіла, способи їх продукування, спосіб лікування хвороби крона, спосіб лікування розсіяного склерозу, фармацевтична композиція
ES521422A0 (es) Procedimiento para la obtencion de derivados de carboxilamida n-glicosilados.
RU92016354A (ru) Композиция, способы лечения, способ предупреждения рецидива, способ усиления цитотоксической активности иммунотоксина, способ усиления цитотоксического действия конъюгата
DK107787D0 (da) Fremgangsmaade og praeparat til behandling af cancer og ikke-maligne tumorer
FI104234B1 (fi) Menetelmä vasta-ainekonjugaattien valmistamiseksi neoplastisten sairauksien hoitoon
EP0684260A3 (de) Aus Gewebe gewonnene Tumorwachstum hemmende Mittel, Verfahren zu ihrer Herstellung und Ihre Verwendungen.
ES498476A0 (es) Procedimiento de preparacion de arn ribosomales bacterianos
BG101038A (bg) Супресия на растежа на туморни клетки посредствомсиндекан- 1 ектоучастък
DE3781652D1 (de) Zubereitung, geeignet fuer die behandlung von darmstoerungen.
DK0393502T3 (da) Opløselige interferon-gamma-receptorer og fremgangsmåder til fremstilling heraf
PT81093B (pt) Processo para a preparacao de uma composicao terapeutica para tratamento de um tumor
PT73950B (fr) Procede de preparation de composes de dichloredietilaminopheni-lalanine d'action antitumureuse
WO1999065517A3 (en) Therapeutic compositions that produce an immune response by altering the antigen
DK46988D0 (da) Fremgangsmaade til fremstilling af katteleukaemivirusantigener og anvendelsen heraf
PL252100A1 (en) Method of obtaining novel derivatives of /4-ketothiazolidynylideno-2/-acetamides
MY103593A (en) Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation
ES8304582A1 (es) Procedimiento para preparar compuestos de estano.
DE3161400D1 (en) 5-alkyl-3-alkylthiopropionthioates, process for their preparation and their use as pharmaceutical compositions
DE3585096D1 (de) Pteridin-derivate, diese enthaltende antikrebs-zubereitung und verfahren zur herstellung dieser derivate.
GB1515392A (en) Process for the purification of protein conjugates
RU93034452A (ru) Производные хиназолинов для усиления противоопухолевой активности, способ их получения, способ лечения и фармацевтическая композиция

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment